 |
 |
 |
| Cdn$ millions, except per share amounts |
| Common Shares |
|
|
| Balance at Beginning of Year |
821 |
732 |
| Exercise of Tandem Options for Shares |
32 |
16 |
| Issue of Common Shares |
24 |
32 |
| Previously Recognized Liability Relating to Stock Options Exercised |
40 |
41 |
| Balance at End of Year |
917 |
821 |
| |
|
|
| Contributed Surplus |
|
|
| Balance at Beginning of Year |
4 |
2 |
| Stock Based Compensation Expense |
1 |
2 |
| Modification of Stock Option Plan to Tandem Option Plan |
(2) |
- |
| Balance at End of Year |
3 |
4 |
| |
|
|
| Retained Earnings |
|
|
| Balance a Beginning of Year |
3,972 |
3,423 |
| Net Income |
1,086 |
601 |
| Dividends on Common Shares |
(53) |
(52) |
| Transition Adjustment for Inventory Standard |
(22) |
- |
| Balance at End of Year |
4,983 |
3,972 |
| |
|
|
| Accumulated Other Comprehensive Loss |
|
|
| Balance at Beginning of Year |
(161) |
(161) |
| Opening Cumulative Foreign CTA |
- |
- |
| Opening Derivatives Designated as Cash Flow Hedges |
61 |
- |
| Other Comprehensive Loss |
(193) |
- |
| Balance at End of Year |
(293) |
(161) |